SCHEMBL30736401

SCHEMBL30736401

C=CC(=O)N1CCC[C@H](C(=O)Nc2ccc(NC(=O)c3cccc(-c4[nH]ncc4Cl)n3)nc2)C1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK14 O94921 6/20 0.45
CCNY Q8ND76 6/20 0.45
NPC1 O15118 4/20 0.43
RAB9A P51151 4/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
ALDH1A1 P00352 2/20 0.43
TP53 P04637 3/20 0.42
LMNA P02545 2/20 0.42
GAA P10253 1/20 0.42
TSHR P16473 1/20 0.42
PTBP1 P26599 1/20 0.42
RHOA P61586 6/20 0.42
PKM P14618 1/20 0.40
HPGD P15428 1/20 0.38
ROCK2 O75116 1/20 0.38
CCR2 P41597 1/20 0.38
ROCK1 Q13464 1/20 0.38
CDK7 P50613 1/20 0.37
CCNH P51946 1/20 0.37
MNAT1 P51948 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27129983 1.00 CDK14 (0.45) CDK14CCNYNPC1RAB9ASMN1; SMN2
SCHEMBL26986517 1.00 CDK14 (0.45) CDK14CCNYNPC1RAB9ASMN1; SMN2
SCHEMBL27084621 0.87 IRAK1 (0.48) CDK14CCNYNPC1RAB9ASMN1; SMN2
SCHEMBL30279687 0.87 IRAK1 (0.48) CDK14CCNYNPC1RAB9ASMN1; SMN2
SCHEMBL23860733 0.87 IRAK1 (0.48) CDK14CCNYNPC1RAB9ASMN1; SMN2
SCHEMBL23860729 0.87 IRAK1 (0.48) CDK14CCNYNPC1RAB9ASMN1; SMN2
SCHEMBL30165298 0.87 IRAK1 (0.48) CDK14CCNYNPC1RAB9ASMN1; SMN2
SCHEMBL26986619 0.87 TP53 (0.39) CDK14CCNYNPC1RAB9ASMN1; SMN2
SCHEMBL26986482 0.86 TP53 (0.38) CDK14CCNYNPC1RAB9ASMN1; SMN2
SCHEMBL26986488 0.85 CDK14 (0.37) CDK14CCNYNPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4551218-A2 POTENT AND SELECTIVE IRREVERSIBLE INHIBITORS OF IRAK1 Dana-Farber Cancer Institute, Inc. (US) 2025-05-14 EP disclosed
WO-2024011116-A2 POTENT AND SELECTIVE IRREVERSIBLE INHIBITORS OF IRAK1 DANA-FARBER CANCER INSTITUTE, INC. (US) 2024-01-11 WO disclosed